Margarida M. Moura

TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas

Miguel Melo, Adriana Gaspar da Rocha, João Vinagre et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 547 citations · Full text

Medicine, Molecular Genetics, Oncology +16

High Prevalence of <i>RAS</i> Mutations in <i>RET</i> -Negative Sporadic Medullary Thyroid Carcinomas

Margarida M. Moura, Branca Cavaco, António E. Pinto et al. · The Journal of Clinical Endocrinology & Metabolism · 2011 · 241 citations

Medicine, Genetics, Oncology +17

Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas

Margarida M. Moura, Branca Cavaco, António E. Pinto et al. · British Journal of Cancer · 2009 · 178 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Cell Cycle Deregulation and<i>TP53</i>and<i>RAS</i>Mutations Are Major Events in Poorly Differentiated and Undifferentiated Thyroid Carcinomas

Jaime Miguel Gomes Pita, Ines Figueiredo, Margarida M. Moura et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 96 citations · Full text

Medicine, Molecular Biology, Oncology +17

Osteopontin expression is correlated with differentiation and good prognosis in medullary thyroid carcinoma

Luciana Bueno Ferreira, Catarina Eloy, Ana Pestana et al. · European Journal of Endocrinology · 2016 · 28 citations

Medicine, Oncology, Pathology +13